Fulvestrant

**Semantic type:** Organic Chemical|Pharmacologic Substance

**Definition:** A synthetic estrogen receptor antagonist. Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. (NCI04)

**Synonyms:** - 7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol - FULVESTRANT - Faslodex - Faslodex - Faslodex(ICI 182,780) - ICI 182,780 - ICI 182780 - ICI-182780 - ICI182780 - ZD 9238 - ZD-9238 - ZD9238 - fulvestrant